Ideas

June 6, 2018

Published by admin_auro at June 6, 2018

Categories

Cluster of differentiation-based therapy for body weight control, energy homeostasis and TIIDM: Cluster of differentiation (CD24) decreases CADM1 and its downstream target genes that inhibit glucose-induced insulin secretion, improves insulin sensitivity, increases energy utilization, promotes weight loss and protects from diet-induced obesity and TIIDM, via up regulation of its target gene, 6/June/2017, 11.52 pm

Introduction: What they say A study from the Max Delbrück Center for Molecular Medicine, Berlin, Germany shows that “Regulation of body weight and energy homeostasis by […]

June 3, 2018

Published by admin_auro at June 3, 2018

Categories

Ideas

Combinatorial therapy for Deafness: A therapeutic mix encompassing Brmocriptine, Cholecalciferol, Ajoene and DIM (BCAD) increases the expression of ATG5 (Autophagy-related 5), prevents aggregation of proteins in inclusion bodies, inhibits hair cell degeneration, improves hearing loss via up regulation of its target genes, 3/June/2018, 11.25 pm

What we say: Dr L Boominathan PhD, Director-cum-chief Scientist of GBMD, reports that: Combinatorial therapy for Deafness: A therapeutic mix encompassing Brmocriptine, Cholecalciferol, Ajoene and DIM (BCAD) increases the […]

June 3, 2018

Published by admin_auro at June 3, 2018

Categories

Ideas
NAFLD

A ceramide way to treat Non-alcoholic fatty liver disease (NAFLD): α-galactosylceramide promotes degradation of HMGCR, decreases the levels of triglycerides, free cholesterol, and total cholesterol and prevents the progression of Non-alcoholic fatty liver disease (NAFLD via down regulation of its target gene, 3/June/2018, 11.18 pm

Significance of the study: Given that: (1) 15-30% of Western populations suffer from Non-alcoholic fatty liver disease (NAFLD), while 6-25% of Asian populations suffer from it; (2) 75 to […]

June 3, 2018

Published by admin_auro at June 3, 2018

Categories

Interleukin-based therapy for body weight control, energy homeostasis and TIIDM: Interleukin-15 (IL-15) decreases CADM1 and its downstream target genes that inhibit glucose-induced insulin secretion, improves insulin sensitivity, increases energy utilization, promotes weight loss and protects from diet-induced obesity and TIIDM, via up regulation of its target gene, 3/June/2017, 11.08 pm

Introduction: What they say A study from the Max Delbrück Center for Molecular Medicine, Berlin, Germany shows that “Regulation of body weight and energy homeostasis by […]